Adaptive Neurostimulation Pattern for Efficacy Maintenance

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current neurostimulation systems face challenges in maintaining efficacy over time, as the prescribed therapy regimen may not stabilize for periods of days or weeks, and the benefits for patients can diminish, necessitating a method to dynamically adjust the pattern of stimulation.

Innovation Solution

The system employs a combination of hardware and software to deliver electrical neurostimulation using implantable pulse generators and leads with segmented electrodes, allowing for precise control of stimulation patterns, including changes in electrode combinations, energy distribution, and timing, based on real-time feedback from biomarker signals to adapt the therapy regimen.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If periodic pulses with uniform waveforms are delivered continuously or in bursts, then the neurostimulation system is simple to operate and program, but the efficacy of the delivered pattern decreases with time

Engineering Contradiction:
Improveefficacy of neurostimulationVSAvoidcomplexity of stimulation pattern
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent implements dynamic neurostimulation by varying multiple parameters (amplitude, pulse width, frequency, electrode configuration) over time according to predetermined patterns. The system transitions between different stimulation configurations within a therapy session, allowing the stimulation pattern to adapt dynamically to maintain efficacy without requiring manual reprogramming or complex decision-making by the user.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The system employs periodic variation of stimulation parameters where different waveform patterns are delivered in alternating intervals. This includes switching between monophasic and biphasic waveforms, varying pulse frequencies in a periodic manner, and cycling through different electrode configurations to prevent tolerance development and maintain therapeutic effectiveness over time.

Inventive Principle:
Principle #19Periodic action

2Reliability

If the neurostimulation pattern is changed to maintain efficacy, then the therapeutic effectiveness is improved, but the system complexity increases

Engineering Contradiction:
Improvetherapeutic effectivenessVSAvoidsystem complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The system incorporates predetermined stimulation patterns and parameter variations that are programmed in advance. Multiple therapy programs with different parameter configurations are pre-established, allowing the system to automatically transition between them according to a schedule or based on simple sensors, eliminating the need for complex real-time decision-making algorithms while maintaining therapeutic effectiveness.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent systematically varies multiple stimulation parameters including amplitude, pulse width, frequency, and electrode configuration to optimize therapeutic effectiveness. By coordinating changes across multiple parameters simultaneously, the system achieves enhanced efficacy while managing complexity through integrated control of all parameters within a unified therapy program framework.

Inventive Principle:
Principle #35Parameter changes

3Ease of manufacture

If uniform waveforms are used for neurostimulation, then the device is easier to manufacture and program, but the stimulation lacks the temporal patterning needed for optimal neural modulation

Engineering Contradiction:
Improveease of programmingVSAvoidtemporal patterning capability
Core Design Contradiction:
Ease of manufactureVSAdaptability or versatility

Solution Approach 1:

The stimulation waveform is segmented into distinct phases including charge injection, stimulation, and recovery periods. Each phase can be independently controlled with different parameters, allowing complex temporal patterns to be constructed from simpler modular components. This segmentation enables versatile waveform shaping while maintaining manageable programming through standardized phase definitions.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The system dynamically adjusts waveform characteristics including switching between monophasic and biphasic configurations, varying pulse durations, and modulating frequency over time. These dynamic changes are implemented through coordinated control of stimulation parameters within predetermined patterns, providing temporal patterning capability while keeping the programming interface manageable through preset program selections.

Inventive Principle:
Principle #15Dynamics

Data Source

PatentEP3609570B1Variation of spatial patterns in time for coordinated reset stimulation
Publication Date: 2023.02.22 BOSTON SCI NEUROMODULATION CORP
  • EP3609570B1 patent drawingFigure 1~2
  • EP3609570B1 patent drawingFigure 3A~3D
  • EP3609570B1 patent drawingFigure 3E~3H

AI summary

This document discusses a medical device for coupling to a plurality of implantable electrodes. The medical device includes a therapy circuit, a biomarker sensing circuit, and a control circuit operatively coupled to the therapy circuit and biomarker sensing circuit. The therapy circuit delivers electrical neurostimulation energy to the plurality of implantable electrodes. The biomarker sensing circuit generates a sensed biomarker signal representative of a physiological biomarker of a subject. The control circuit initiates delivery of bursts of pulses of the electrical neurostimulation energy to the plurality of the implantable electrodes according to a first therapy regimen and monitor efficacy of the delivered electrical neurostimulation energy using the sensed biomarker signal; and changes the electrical neurostimulation to a second therapy regimen upon detecting a reduction in the efficacy of the first therapy regimen using the sensed biomarker signal.